State Street’s Senti Biosciences Holdings SNTI Stock Holding History

State Street’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,010	Closed	-$8.13K	–	4268
2026 Q1	$8.13K	Hold	10,010	–	–	﹤0.01%	4257
2025 Q4	$10.4K	Hold	10,010	–	–	﹤0.01%	4267
2025 Q3	$14.1K	Hold	10,010	–	–	﹤0.01%	4263
2025 Q2	$21.1K	Hold	10,010	–	–	﹤0.01%	4199
2025 Q1	$33.6K	Hold	10,010	–	–	﹤0.01%	4147
2024 Q4	$35.1K	Buy	+10,010	New	+$31.9K	﹤0.01%	4163
2024 Q3	–	Sell	-3,910	Closed	-$10.8K	–	4333
2024 Q2	$10.8K	Hold	3,910	–	–	﹤0.01%	4320
2024 Q1	$14.7K	Hold	3,910	–	–	﹤0.01%	4314
2023 Q4	$25.8K	Hold	3,910	–	–	﹤0.01%	4316
2023 Q3	$16.6K	Hold	3,910	–	–	﹤0.01%	4467
2023 Q2	$24.4K	Hold	3,910	–	–	﹤0.01%	4569
2023 Q1	$46.1K	Hold	3,910	–	–	﹤0.01%	4519
2022 Q4	$55.1K	Buy	+3,910	New	+$95.4K	﹤0.01%	4538

Other funds holding SNTI

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MVM

Menlo Ventures Management Menlo Park, California $357M AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

State Street's SNTI Position: Q2 2026 in Review

State Street sold out of Senti Biosciences Holdings (SNTI) in Q2 2026, closing a stake of 10,010 shares — an estimated $8.13K sold.

State Street first reported a position in SNTI in Q4 2022 and held it in 13 quarters. The position peaked at $55.1K in Q4 2022. 19 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

State Street reported no remaining Senti Biosciences Holdings position as of Q2 2026 after selling out during the quarter.
State Street sold 10,010 Senti Biosciences Holdings shares in Q2 2026, an estimated $8.13K.
State Street first reported a position in Senti Biosciences Holdings in Q4 2022 and held it in 13 quarters.
State Street's Senti Biosciences Holdings position peaked at $55.1K in Q4 2022.
19 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.